Study Title
CFOR258D2416
Purpose
To evaluate the safety of Foradil when added to inhaled corticosteroids, fluticasone propionate
Eligibility
Contact Principal Investigator for Information
Study Process
Patients ages 12 and up with a known history of asthma for at least 1 year will be enrolled. Patients will be randomly assigned to receive Fluticasone propionate 100mcg, 250mcg or 500mcg along with Foradil 12mcg or placebo. Albuterol will be provided for rescue.
Trial Details
Investigator:
Gerry San Pedro, M.D.
IRB:
Quorum
IRB Number:
Trial Type:
Drug
Sponsor:
Novartis Pharmacy
Contact Information:
(318) 212-8130